Tekla Capital Management LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 131 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,634,000
-18.8%
162,5990.0%0.06%
-9.9%
Q1 2022$2,013,000
-45.9%
162,5990.0%0.07%
-40.8%
Q4 2021$3,719,000
-33.5%
162,599
-35.7%
0.12%
-33.3%
Q3 2021$5,595,000
+8.5%
252,821
-36.5%
0.18%
+7.1%
Q2 2021$5,157,000
-0.2%
397,9200.0%0.17%
-5.6%
Q1 2021$5,167,000
+24.3%
397,920
+32.4%
0.18%
+21.9%
Q4 2020$4,157,000
-6.1%
300,6110.0%0.15%
-12.0%
Q3 2020$4,428,000
+200.2%
300,611
+231.1%
0.17%
+196.4%
Q2 2020$1,475,000
+12.0%
90,7880.0%0.06%
-6.7%
Q1 2020$1,317,000
-28.4%
90,7880.0%0.06%
-14.3%
Q4 2019$1,839,00090,7880.07%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders